🔍 From subscriber‼️
🤖 EA name: Gold Vortex EA
📦 Version: 2.00
💻 Platform: MT4 (1470)
🛠Vendor/Source: MQL5
📈 Strategy: Order grid
⏰ Timeframe: m15
🌍 Currency pairs: XAUUSD
🌓 Trading time: Around the clock
⚠️ Attention: Recommended best VPS, BROker
📊 Monitorings found: –
🔬Monitoring by ea_forexlab: –
⏳ Test period: 2020.01.10 – 2026.03.01
🏛 Tick Data Provider: Darwinex (TDSv2)
🧭 GMT: +2; DST: US
Real spread: ✅
Slippage: ❌
In order to download an adviser with tests, go to our telegram channel 👇
The retail market is full of gold robots that promise precision, stability, and “smart” automation, yet most reviews still make the same mistake: they compare headline profit without examining how that profit was produced. You can learn about our approach to testing expert advisors on tick history with a real spread on the relevant page – Our principles.
MEDICI EA is the kind of robot that can be misunderstood very quickly if the reviewer looks only at the balance curve. On the official MQL5 page for MEDICI v2, the vendor describes it as a long-term XAUUSD system for M15, built around “advanced neural networks,” an “advanced algorithm,” and what the author calls a “safe martingale betting system.” The page recommends a minimum $500 investment, low-latency VPS, and specifically says to use it on XAUUSD M15. It also claims the robot can exploit martingale “in the most safest way” and mentions long-term trading with a suggested one-year investment horizon.
That description already tells you what matters most in this review. MEDICI is not a clean directional model. It is not a classic swing system. It is not a low-risk gold scalper. It is a gold martingale/recovery EA, and that changes the entire analytical framework.
This article is based on the published Tick Data Suite backtest with real spread for XAUUSD M15, plus the supporting screenshots showing:
- the long-run equity/drawdown path,
- a trade example on chart,
- long-versus-short trade composition,
- hourly profit/loss distribution,
- and trade-duration distribution.
Why MEDICI EA must be judged differently
A martingale or recovery-style EA cannot be assessed the same way as a standard single-entry strategy.
With a conventional EA, you can often start with:
- profit factor,
- average trade,
- drawdown,
- and curve shape.
With a martingale-style robot, those are still important, but they are not enough. The real questions become:
- How much of the result depends on recovery logic rather than primary signal quality?
- How large is the hidden tail risk?
- How often does the system add or maintain exposure under pressure?
- Does the backtest show real edge, or just survival under favorable historical conditions?
- How much room is there for live-performance degradation before the result becomes unattractive?
Those questions matter especially on gold, where volatility clusters and directional bursts can punish averaging logic much faster than major FX pairs.
What the vendor page claims
The official MEDICI v2 page makes several notable claims:
- It is designed for long-term trading.
- It is recommended for XAUUSD on M15.
- It uses an advanced neural network and a “safe martingale betting system.”
- The vendor highlights “8 years of XAUUSD trading knowledge” and says the system is only minimally affected by news and unexpected price spikes.
- Recommended setup includes at least $500, VPS, and broker choices such as Exness, IC Markets, and RoboForex.
From a professional perspective, these claims are mostly marketing language except for two practically important facts: XAUUSD M15 and martingale. Those two details are the real center of gravity in the review.
Backtest summary from the reviewed TDS report
The reviewed TDS report shows:
- Symbol: XAUUSD
- Timeframe: M15
- Test window: 2020-01-10 to 2026-02-20
- Modelling quality: 99.90%
- Spread: Variable
- Initial deposit: $1,000
Key statistics from the screenshot:
- Total net profit: 140.50
- Profit factor: 2.25
- Expected payoff: 0.60
- Absolute drawdown: 19.09
- Maximal drawdown: 53.84
- Relative drawdown: 4.73%
- Total trades: 233
- Profit trades: 177, or 75.97%
- Loss trades: 56, or 24.03%
- Largest profit trade: 12.62
- Largest loss trade: -12.62
- Average profit trade: 1.43
- Average loss trade: -2.01
At first glance, these are attractive numbers.
A casual reviewer might say:
- PF 2.25 is good,
- drawdown under 5% is very good,
- equity curve is smooth,
- therefore the system is strong.
That conclusion would be too simplistic.
First conclusion: the backtest is neat, but the edge is small
The most important fact in the report is not the drawdown. It is the small scale of the edge.
Over roughly six years of testing, the EA generates only 140.50 of net profit on a $1,000 initial deposit. That is profitable, but modest. The expected payoff of 0.60 also confirms that the per-trade edge is not large.
This matters because small-edge systems have less room for live degradation.
When a robot shows:
- modest expected payoff,
- modest total return,
- and uses martingale/recovery logic,
the correct question is not “Did it make money?” The correct question is “How much of that result disappears if live conditions are slightly worse than the backtest?”
That is where the smoothness of the curve can become deceptive.
Trade structure analysis: respectable on the surface, but still martingale-dependent
The average trade numbers look reasonable at first:
- Average winner: 1.43
- Average loser: -2.01
That is not a disastrous ratio. It is much better than some low-quality martingale EAs that survive on tiny winners and catastrophic losers.
The win rate is also solid:
- 75.97% winners
- 24.03% losers
That combination explains why the curve rises with relatively limited visible stress.
But the parameter block in the screenshot makes the structural issue explicit. It includes a section labeled Martingale System, with settings such as Mart_ONOFF=true and Multiplier=1. Even if the multiplier in this specific test is restrained, the strategy is still built around recovery/averaging logic as part of its design, not as a rare optional feature. That means the clean trade summary cannot be read as if every trade were independent. The system’s behavior has to be judged as a managed recovery engine. The published TDS report shows the martingale section directly in the input list.
That is a critical distinction.
The backtest statistics are telling you how well the recovery structure survived this sample, not just how good the entry logic was.
Equity curve analysis: smooth, but not powerful
The equity/drawdown chart is visually appealing.
The balance line rises gradually from 2020 through early 2026. Drawdowns are shallow and mostly contained. There are several visible pressure clusters, especially:
- around mid-2021,
- mid-2022,
- the second half of 2023,
- late 2024,
- and a longer rough patch in late 2025 into early 2026.
Even so, the drawdowns remain relatively mild in the context of the chart.
That is the strongest argument in favor of MEDICI EA.
However, a professional review has to ask what this smoothness is worth in absolute terms. The answer is: not enough to justify excitement.
Why?
Because the system traded for years, used recovery logic, and still produced only a moderate final profit. In other words, the curve is smooth, but it is not especially efficient. It is a polite-looking curve, not an economically powerful one.
That difference matters. There are many EAs that can produce a calm backtest if the trade size is small enough and the recovery logic is allowed enough time to work. Calmness alone is not the same thing as strength.
Trade-duration analysis: mostly fast, but not purely instant
The duration histogram is useful because it shows what MEDICI actually does in the market.
The dominant bucket is clearly:
- 5 minutes
There are also smaller clusters in:
- 10 minutes
- 15 minutes
- 30 minutes
- 1 hour
- 2 hours
- and 8 hours
There is almost no meaningful activity beyond that.
This tells us two things.
First, despite the vendor’s “long-term trading” wording, the attached test behaves much more like a short-horizon intraday system than a true long-hold model.
Second, the strategy appears to close most trades quickly, which reduces one kind of risk but increases another: execution sensitivity. Fast-closing gold systems are more vulnerable to spread quality, fill quality, and short-term volatility distortion than slower, higher-timeframe systems with wider structural edges.
So the duration chart is not just descriptive. It changes the interpretation of the whole EA. This is not really a long-term gold robot in practical trading behavior. It is a quick-reaction M15 gold recovery model.
Long versus short exposure: heavily long-biased
The long/short pie chart shows:
- Long trades: 82%
- Short trades: 18%
That is a major structural bias.
It means MEDICI is not a neutral bidirectional gold system. It is predominantly positioned to exploit long-side behavior.
That may have worked historically. Gold has had extended bullish tendencies over parts of the sample. But it also creates a clear live-trading risk: if future gold conditions favor more violent downside continuation or less forgiving rebound behavior, the edge could weaken.
This is important because a lot of retail traders look at a profitable XAUUSD backtest and assume the robot has general gold expertise. The trade-composition chart says otherwise. The EA appears much more specialized than the marketing language implies.
Hour-of-day profitability analysis: clustered edge, not universal edge
The hourly P/L chart gives another important clue.
The strongest positive contributions appear roughly around:
- 01:00
- 15:00
- 17:00
- 18:00
- and to a lesser extent 19:00–21:00
There are also weaker or negative pockets around:
- 06:00
- 13:00
- 16:00
- 20:00
- and scattered smaller losses elsewhere.
This tells us the strategy does not have a uniform edge across the day. It seems to work better in particular windows and less reliably in others.
That matters because when an EA has:
- a thin absolute edge,
- a time-clustered edge,
- and martingale/recovery logic,
the live-transfer risk rises. A small deterioration during its strongest time windows can disproportionately affect the overall result.
The hourly chart therefore supports a cautious interpretation, not an aggressive one.
The chart example: tactical long-side behavior, not broad adaptive intelligence
The trade example screenshot shows clustered long-side entries around local downside exhaustion and rebound points. Visually, the behavior looks more like tactical reaction trading than broad market-adaptive intelligence.
That is not a criticism by itself. Many good systems are tactically narrow.
But it does matter because the vendor page leans heavily on language like:
- “advanced neural network,”
- “advanced algorithm,”
- and adaptive market response.
The actual available evidence looks much narrower and more conventional:
- strong long bias,
- short holding times,
- controlled but modest edge,
- and visible recovery-style structure.
That does not make the EA bad. It does mean the marketing language appears to be broader than the trading behavior actually demonstrated.
Main strengths of MEDICI EA
1. The backtest is clean and believable
The report does not look like an absurd fantasy curve. It looks plausible.
2. Drawdown is low
A 4.73% relative drawdown is a strong point.
3. The average-trade profile is not disastrous
Average losses are larger than average wins, but not by an extreme amount.
4. Trade sample is meaningful enough
With 233 trades, this is not a one-month toy result.
5. The system appears controlled rather than reckless
Even as a martingale-based design, the attached test does not show the chaotic equity violence common in low-quality recovery bots.
Main weaknesses of MEDICI EA
1. The absolute edge is small
140.50 net profit over a long sample is modest.
2. Martingale is part of the design
The vendor openly markets a “safe martingale betting system,” and the report parameters confirm martingale settings are active in the test.
3. Vendor framing overstates the style
The page describes long-term trading, but the duration chart shows mostly short-hold behavior.
4. The system is heavily long-biased
That increases regime dependence.
5. Thin edge plus gold plus martingale is not a comfortable combination
Even when the drawdown is low in-sample, this mix deserves caution.
How strong is this result by professional standards?
By low-end retail standards, this is a decent report.
By stricter professional standards, it is respectable but limited.
That is the right balance.
The backtest is not weak.
The structure is not nonsense.
The drawdown is controlled.
But the result is still built on a thin edge, narrow bias, and martingale architecture.
So the correct conclusion is not “this EA is excellent,” and not “this EA is junk.”
The correct conclusion is:
MEDICI EA shows a controlled historical result, but not a deep enough edge to justify strong confidence.
Final verdict
MEDICI EA is better than many retail martingale EAs because reviewed TDS report is calm, profitable, and not visibly unstable. That matters.
But the deeper reading is less flattering than the balance line:
- the edge is small,
- the style is heavily long-biased,
- the intraday timing matters,
- the strategy relies on martingale logic,
- and the vendor’s “long-term adaptive neural” framing looks broader than the actual trade behavior shown in the attachments.
The most accurate professional conclusion is this:
MEDICI EA is a controlled but modest gold recovery system. It is not an obvious disaster, but it is also not strong enough to justify a high-conviction rating on the available evidence alone.
Bottom line
The shortest honest summary is this:
MEDICI EA shows a believable TDS real-spread backtest on XAUUSD M15 with low drawdown and smooth growth, but the actual edge is modest, structurally long-biased, and still dependent on martingale-based recovery logic. It deserves cautious interest, not blind trust.
Even more advisors with test results are presented in our advisor database.